首页> 美国卫生研究院文献>Journal of Child and Adolescent Psychopharmacology >NWP06 an Extended-Release Oral Suspension of Methylphenidate Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study

【2h】

NWP06 an Extended-Release Oral Suspension of Methylphenidate Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study

机译：NWP06哌醋甲酯的延长口服混悬液在实验室课堂研究中与安慰剂相比改善了注意力缺陷/多动障碍症状

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectiveThe purpose of this study was to determine the efficacy of NWP06, a novel extended-release (ER) liquid formulation of methylphenidate (MPH), compared with placebo in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children in a laboratory school.

机译：目的本研究旨在确定NWP06（一种新型哌醋甲酯（MPH）缓释（ER）液体制剂）与安慰剂相比在实验室中治疗儿童注意力不足/多动障碍（ADHD）的功效学校。

著录项

期刊名称 Journal of Child and Adolescent Psychopharmacology
作者
Sharon B. Wigal; Ann C. Childress; Heidi W. Belden; Sally A. Berry;
展开▼
作者单位

展开▼
年(卷),期 -1(23),1
年度 -1
页码 3–10
总页数 8
原文格式 PDF
正文语种
中图分类药学;精神病学;儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study [J] . WigalS.B., ChildressA.C., BeldenH.W., Journal of child and adolescent psychopharmacology . 2013,第1期

机译：NWP06是哌醋甲酯的缓释口服混悬液，在实验室课堂研究中与安慰剂相比，改善了注意力缺陷/多动症症状
2. Efficacy and Safety of Extended-Release Dexmethylphenidate Compared with d,l-Methylphenidate and Placebo in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A 12-Hour Laboratory Classroom Study [J] . Rafael Muniz M.D. Matthew Brams M.D. Alice Mao M.D. Kevin McCague M.AL. Pestreich M.A. and Raul Silva M.D. Journal of Child and Adolescent Psychopharmacology . 2008,第3期

机译：延长发布的右甲基哌醋甲酯与d，1-甲基哌醋甲酯和安慰剂相比对注意力不足/多动障碍儿童的疗效和安全性：12小时实验室研究
3. Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: A 12-hour laboratory classroom study [J] . MunizR., BramsM., MaoA., Journal of child and adolescent psychopharmacology . 2008,第3期

机译：右旋哌醋甲酯与d，l-哌醋甲酯和安慰剂相比，缓释药治疗儿童注意力不足/多动障碍的有效性和安全性：一项12小时的实验室课堂研究
4. The Theta/Beta Ratio as an Indicator of Evolution in Pediatric Patients Treated for Attention-Deficit/Hyperactivity Disorder (ADHD) A Retrospective Study [C] . Maria Evangelina Herran-Paz, Raul Ortiz-Monasterio, Antonio Rodriguez-Diaz, International Conference on Bio-inspired Systems and Signal Processing . 2015

机译：θ/β比例作为对注意力缺陷/多动障碍（ADHD）治疗的儿科患者进化的指标（ADHD）回顾性研究
5. Effectiveness of methylphenidate and combined treatment (methylphenidate and psychosocial treatment) for Chinese children with attention-deficit/hyperactivity disorder in a community mental health center. [D] . So, Yuk-chi. 2005

机译：哌醋甲酯和联合治疗（哌醋甲酯和社会心理治疗）对中国社区精神卫生中心注意力不足/多动障碍儿童的有效性。
6. Efficacy Safety and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting [O] . Ann C. Childress, Scott H. Kollins, Andrew J. Cutler, -1

机译：6-12岁患有注意力缺陷/多动障碍的儿童在实验室教室环境中口服释放崩解哌醋甲酯片的疗效安全性和耐受性
7. Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting [O] . Ann C. Childress, Scott H. Kollins, Andrew J. Cutler, 2017

机译：在6-12岁时延长释放口腔崩溃甲基蛋白片剂的功效，安全性和耐受性，在实验室课堂环境中的注意力/多动障碍中

NWP06 an Extended-Release Oral Suspension of Methylphenidate Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅